Ms Margaret Littlejohn
Honorary (Fellow)
Department of Infectious Diseases
44 Scholarly works
8 Projects
HIGHLIGHTS
2025
Journal article
Disease progression & treatment need in sub-genotype C4 hepatitis B infection: a retrospective cohort study in the Northern Territory, Australia
DOI: 10.1186/s12879-025-11213-w2024
Journal article
CRISPR-Cas13b-mediated suppression of HBV replication and protein expression
DOI: 10.1016/j.jhep.2024.05.0252024
Journal article
High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy
DOI: 10.1111/liv.160292024
Journal article
Hepatitis B genotypes in Aboriginal and Torres Strait Islander Australians: correlation with clinical course and implications for management
DOI: 10.1111/imj.161812022
Research Grant
Developing a Novel RNA Therapeutic for Chronic Hepatitis B
2022
Research grants (other domestic)
Developing a Novel RNA Therapeutic for Chronic Hepatitis B
2022
Internal Research Grant
Developing a Novel RNA Therapeutic for Chronic Hepatitis B
RECENT SCHOLARLY WORKS
2023
Journal article
Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants
DOI: 10.1097/HC9.00000000000001882023
Journal article
Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B
DOI: 10.1111/apt.172992022
Journal article
Preventing early childhood transmission of hepatitis B in remote aboriginal communities in Northern Australia
DOI: 10.1186/s12939-022-01808-z2022
Journal article
Secreted hepatitis B virus splice variants differ by HBV genotype and across phases of chronic hepatitis B infection
DOI: 10.1111/jvh.137022022
Journal article
Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels
DOI: 10.1111/apt.169682022
Journal article
Evaluation of dried blood spots for hepatitis B and D serology and nucleic acid testing
DOI: 10.1002/jmv.25485
RECENT PROJECTS
2025
Research grants (other domestic)
Development of a Pre-Clinical Mouse Model for Assaying Antivirals Against HBV
2024
Research grants (other domestic)
Development of a Point of Care Assay for the Hepatitis B E Antigen